MSME (Udyam registered) Ministry of MSME
- Category
- Medium (2023-24)
- Udyam number
- UDYAM-DD-01-0001819
Mapra Laboratories Pvt Ltd - pharma in Mumbai, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹184.45 Cr
▲ 5% YoY
Net profit · FY 2025
₹30.43 Cr
Net margin 16.5%
EBITDA · FY 2025
₹39.5 Cr
EBITDA margin 21.4%
Authorised capital
₹15 Lakh
Registered with MCA
Paid-up capital
₹15 Lakh
Issued & subscribed
Satisfied charges
₹4.05 Cr
No open charges
Company age
41 yrs
Est. 1985
Employees · EPFO
654
Provident fund records
About Mapra Laboratories Pvt Ltd
Data last updated:
Mapra Laboratories Pvt Ltd is a private limited company based in Mumbai, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 04 November 1985 and has been in existence for over 41 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24100MH1985PTC037946. Its GSTIN is 27AAACM5060F1ZQ (Maharashtra). The company holds 16 GST registrations, of which 13 are active.
The company has an authorised share capital of ₹15 Lakh and a paid-up capital of ₹15 Lakh. It is led by directors Randhir Kumar Bachan and Mukesh Kumar.
Its last annual general meeting (AGM) was held on 05 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 201 Adhyarsh Industrialestate Sun Mill Compound Lower Parel, Mumbai, Maharashtra, India – 400013.
As per the financials filed for FY 2025, the company reported a revenue of ₹184.45 Cr, a growth of 5% compared to the previous year. For the same year it recorded a net profit of ₹30.43 Cr (net margin 16.5%) and EBITDA of ₹39.5 Cr (EBITDA margin 21.4%). Revenue has grown at a compounded annual rate (CAGR) of 3% over three years and 5% over five years.
The company has about 654 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Mapra. As per MCA filings, the company has satisfied charges of ₹4.05 Cr on record. Court records list 18 cases involving the company, including 12 filed by the company and 6 filed against it; 1 case is pending. The company has 7 deals on record (7 secondary share transfers); the latest was in June 2018. Its 9 peer companies in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 4 larger and 5 smaller; the largest is Parnax Lab Limited with revenue of ₹189.41 Cr. The company has 15 MSME Form 1 returns on record between 2019 and 2023, listing 1,565 overdue payments to 79 micro and small suppliers.
Mapra Laboratories Pvt Ltd is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-DD-01-0001819). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website mapra.com.
Company details
CIN U24100MH1985PTC037946
Registration Number 037946
Incorporation Date 04 November 1985
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 05 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Medium
Udyam Registration UDYAM-DD-01-0001819
Recognitions & Rankings of Mapra Laboratories
Contact details
Mapra Laboratories Pvt Ltd's registered office is in Mumbai, Maharashtra. Its website is mapra.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered Address201 Adhyarsh Industrialestate Sun Mill Compound Lower Parel, Mumbai, Maharashtra, India – 400013
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Mapra Laboratories Pvt Ltd, buy the company report.
Comprehensive company report
Mapra Laboratories Pvt Ltd - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Mapra Laboratories is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Mapra Laboratories Pvt Ltd, buy the company report.
Financials of Mapra Laboratories Pvt Ltd
FY 2025 filings availableMapra Laboratories Pvt Ltd reported revenue of ₹184.45 Cr (up 5% YoY) for FY 2025.
Revenue · FY 2025
₹184.45 Cr ▲ 5%
Net profit · FY 2025
₹30.43 Cr margin 16.5%
EBITDA · FY 2025
₹39.5 Cr margin 21.4%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 5%
3 years · compounded
▲ 3%
5 years · compounded
▲ 5%
EBITDA CAGR growth
1 year
▲ 33%
3 years · compounded
▲ 18%
5 years · compounded
▲ 13%
Revenue has grown at a compounded annual rate (CAGR) of 5% over five years, including 5% growth in the latest year. EBITDA rose 33% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹39.5 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹30.43 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 21.4% | ||||
| Net Profit Margin | 16.5% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Mapra Laboratories Pvt Ltd, buy the company report.
Board of directors of Mapra Laboratories Pvt Ltd
Mapra Laboratories has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Randhir Kumar Bachan Also directs: Aristo Pharmaceuticals Private Limited | Director | 07 Jan 2000 | 26 Years 9 Months | Current |
| Mukesh Kumar | Director | 02 Aug 2018 | 8 Years 2 Months | Current |
Peer comparison
Mapra Laboratories Pvt Ltd is compared with the 9 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Parnax Lab Limited | ₹189.41 Cr (FY 2025) | 0.0% | Mumbai, Maharashtra, India | |||
| Regenix Drugs Limited | ₹188.37 Cr (FY 2024) | 9.0% | Chennai, Tamil Nadu, India | |||
| Goldencross Pharma Limited | ₹187.87 Cr (FY 2025) | 31.0% | Mumbai, Maharashtra, India | |||
| Comed Chemicals Limited | ₹187.35 Cr (FY 2025) | 12.0% | Vadodara, Gujarat, India | |||
| Mapra Laboratories Pvt Ltdthis company | ₹184.45 Cr (FY 2025) | ₹30.43 Cr | 16.5% | 5.0% | 654 | Mumbai, Maharashtra, India |
| Naxpar Pharma Private Limited | ₹183.89 Cr (FY 2025) | 1.0% | Mumbai, Maharashtra, India | |||
| Infutec Healthcare Limited | ₹183.11 Cr (FY 2021) | -22.0% | Mumbai, Maharashtra, India | |||
| Sakar Healthcare Limited | ₹178.9 Cr (FY 2025) | 14.0% | Changodar, Gujarat, India | |||
| Stanford Laboratories Private Ltd | ₹178.12 Cr (FY 2025) | 3.0% | New Delhi, Delhi, India | |||
| BDR Lifesciences Private Limited | ₹176.87 Cr (FY 2025) | -5.0% | Vadodara, Gujarat, India |
To see the full peer comparison of Mapra Laboratories Pvt Ltd, buy the company report.
Auditor
Mapra Laboratories Pvt Ltd is audited by R S Prabhu & Associates for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| R S Prabhu & Associates | FY 2023 | 127010W |
Shareholding
The shareholding of Mapra Laboratories Pvt Ltd is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Mapra Laboratories Pvt Ltd, buy the company report.
Charges & borrowings
Open charges
None
Satisfied charges
₹4.05 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 26 May 1993 | 80068297 | State Bank of India | ₹1.7 Cr | Satisfied | |
| 22 Nov 1988 | 80068296 | State Bank of India | ₹2.35 Cr | Satisfied |
To see the full charge records of Mapra Laboratories Pvt Ltd, buy the company report.
Total charge records: 2 View all charges
Deals & funding
Mapra Laboratories Pvt Ltd has 7 deals on record (7 secondary share transfers); the latest was in June 2018.
Total deals
7
Secondary share transfers
7
Deals on record (5 of 7)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Jun 2018 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
| Mar 2016 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
| May 2015 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
| Mar 2015 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
| Aug 2011 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
To see the full deal history of Mapra Laboratories Pvt Ltd, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Mapra Laboratories Pvt Ltd has 18 court cases on record: 12 filed by Mapra Laboratories, 6 filed against it. 1 case is pending and 17 are disposed.
Total cases
18
Filed by the company
12
Filed against the company
6
Pending
1
Disposed
17
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 15 | 4 | 0 |
| District courts | 2 | 1 | 1 |
| Supreme Court | 1 | 1 | 0 |
Cases on record (5 of 18)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Muzaffarpur, Bihar | Court case (Drugs and Cosmetics Act) | Filed against the company by State of Bihar Through MD. Parwez Akhtar | Pending |
| Supreme Court | Court case (2404-Indirect Taxation : Value Added Tax (VAT), State Sales Tax Act) | Filed against the company by The State of Bihar Commercial Taxes Department Principal Secretary the State of Bihar Commercial Taxes Department and 2 others | Disposed |
| High Court | Court case (C. REV.) | Filed against the company by The State of Bihar and Ors and 2 others | Disposed |
| High Court | Court case (CWJC) | Filed by the company against The State of Bihar and Ors and 2 others | Disposed |
| Bombay High Court | Writ petition | Filed by the company against The Union of India and Anr | Disposed |
To see the full case history of Mapra Laboratories Pvt Ltd, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
Mapra Laboratories Pvt Ltd has 15 MSME Form 1 returns on record between 2019 and 2023, listing 1,565 overdue payments to 79 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 79)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| an individual supplier | |||
| an individual supplier | |||
| an individual supplier | |||
| Hindustan Phosphates Private Limited | |||
| Radhe International |
To see the full MSME payment records of Mapra Laboratories Pvt Ltd, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Employees & EPFO
Mapra Laboratories Pvt Ltd has a workforce of 654 employees on its EPFO records as of Apr 05, 2024, across 1 active EPFO establishment.
Employee count
654
Active EPFO establishments
1
Employee growth
1.87%
GST
Mapra Laboratories has 16 GST registrations: 13 active and 3 cancelled or inactive. The first 4 active GSTINs are listed below.
Total GSTINs
16
Active
13
Cancelled / inactive
3
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAACM5060F1ZQ | Maharashtra | Active | 01 Jul 2017 |
| 27AAACM5060F2ZP | Maharashtra | Active | 20 Mar 2019 |
| 08AAACM5060F1ZQ | Rajasthan | Active | 01 Jul 2017 |
| 09AAACM5060F1ZO | Uttar Pradesh | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Mapra Laboratories Pvt Ltd, buy the company report.
Recent activity
Mapra Laboratories Pvt Ltd has 6 board changes on record since 1985: 4 appointments and 2 cessations. The latest: Jai Ram Singh ceased to be Director on 14 Oct 2023.
AGM
Mapra Laboratories Pvt Ltd last Annual general meeting of members was held on 05 Sep 2025 as per latest MCA records.
Filing
Mapra Laboratories Pvt Ltd has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai.
Ceased
Jai Ram Singh ceased to be Director.
Charges
A charge registered on 22 Nov 1988 via Charge ID 80068296 with State Bank Of India was fully satisfied on 24 May 2021.
Ceased
Rajeev Sharma ceased to be Director.
Appointed
Mukesh Kumar was appointed as Director.
Charges
A charge with State Bank Of India of Rs. 235.00 Lakh registered on 22 Nov 1988 with Charge ID 80068296 was modified on 31 Aug 2016.
Charges
A charge registered on 26 May 1993 via Charge ID 80068297 with State Bank Of India was fully satisfied on 28 Jun 2016.
Appointed
Randhir Kumar Bachan was appointed as Director.
Appointed
Jai Ram Singh was appointed as Director.
Charges
A charge with State Bank Of India of Rs. 170.00 Lakh registered on 26 May 1993 with Charge ID 80068297 was modified on 31 May 1993.
Charges
A charge with State Bank Of India amounted to Rs. 170.00 Lakh with Charge ID 80068297 was registered on 26 May 1993.
3 earlier events are in the company report.
Frequently asked questions
Mapra Laboratories is an active private limited company based in Mumbai, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 04 November 1985 (41+ years old) and is registered under CIN U24100MH1985PTC037946.
Mapra Laboratories has 2 current directors:
- Randhir Kumar Bachan - Director
- Mukesh Kumar - Director
The latest financial statements of Mapra Laboratories on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 05 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Mapra Laboratories is 27AAACM5060F1ZQ, registered in Maharashtra. The company has 16 GST registrations in all, of which 13 are active and 3 are cancelled or inactive. Other active GSTINs include 27AAACM5060F2ZP (Maharashtra), 08AAACM5060F1ZQ (Rajasthan), 09AAACM5060F1ZO (Uttar Pradesh).
The CIN (Corporate Identification Number) of Mapra Laboratories is U24100MH1985PTC037946. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Mapra Laboratories has 18 court cases on record: 12 filed by the company and 6 filed against it. 1 is pending. Most are in the high courts.
Mapra Laboratories was incorporated on 04 November 1985, making it 41+ years old. It is registered with the Registrar of Companies, Mumbai.
Mapra Laboratories has 7 deals on record (7 secondary share transfers); the latest was in June 2018.
The peers of Mapra Laboratories by revenue are Parnax Lab Limited, Regenix Drugs Limited, Goldencross Pharma Limited, Comed Chemicals Limited, Naxpar Pharma Private Limited and 4 more, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Jai Ram Singh ceased to be Director on 14 Oct 2023. Rajeev Sharma ceased to be Director on 25 Sep 2018. Mukesh Kumar was appointed as Director on 02 Aug 2018. Mapra Laboratories has 6 board changes on record in total.
Yes, Mapra Laboratories is registered as a medium enterprise under Udyam registration (number: UDYAM-DD-01-0001819).
Mapra Laboratories has 15 MSME Form 1 returns on record between 2019 and 2023, listing 1,565 overdue payments to 79 micro and small suppliers. The latest return was filed on 04 Jan 2024.